Key statistics
On Thursday, Orchestra Biomed Holdings Inc (OBIO:NMQ) closed at 4.81, 13.98% above the 52 week low of 4.22 set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.91 |
---|---|
High | 4.99 |
Low | 4.74 |
Bid | 4.64 |
Offer | 4.86 |
Previous close | 5.00 |
Average volume | 43.32k |
---|---|
Shares outstanding | 37.82m |
Free float | 24.69m |
P/E (TTM) | -- |
Market cap | 189.12m USD |
EPS (TTM) | -1.57 USD |
Data delayed at least 15 minutes, as of Oct 10 2024 21:00 BST.
More ▼
Announcements
- Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
- Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors
- Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
- Orchestra BioMed to Participate in Jefferies Global Healthcare Conference
- Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
- Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
- Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
- Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
- Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors
- Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
More ▼